| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 251.816 | 237.578 | 224.747 | 219.088 | 231.747 | 266.623 | 245.939 | 191.036 | 152.551 | 161.675 |
| Total Income - EUR | 254.439 | 237.922 | 224.916 | 219.112 | 231.749 | 266.687 | 245.951 | 231.377 | 152.565 | 161.683 |
| Total Expenses - EUR | 232.888 | 220.598 | 221.936 | 200.580 | 218.150 | 227.796 | 221.046 | 175.002 | 146.963 | 154.503 |
| Gross Profit/Loss - EUR | 21.551 | 17.324 | 2.979 | 18.533 | 13.599 | 38.891 | 24.905 | 56.376 | 5.602 | 7.180 |
| Net Profit/Loss - EUR | 18.090 | 14.551 | 788 | 16.342 | 11.282 | 36.225 | 22.446 | 54.064 | 4.077 | 3.179 |
| Employees | 9 | 9 | 9 | 8 | 8 | 8 | 7 | 6 | 4 | 4 |
Check the financial reports for the company - Speranta Farmexim Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 158 | 6 | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 98.214 | 104.876 | 101.178 | 116.830 | 130.209 | 149.710 | 167.093 | 185.184 | 199.832 | 195.421 |
| Inventories | 44.960 | 78.794 | 71.194 | 84.171 | 99.504 | 127.840 | 138.842 | 141.009 | 151.988 | 169.290 |
| Receivables | 23.669 | 2.420 | 23.647 | 29.763 | 24.954 | 18.076 | 21.005 | 20.290 | 23.907 | 19.622 |
| Cash | 29.584 | 23.661 | 6.337 | 2.896 | 5.751 | 3.794 | 7.246 | 23.885 | 23.937 | 6.508 |
| Shareholders Funds | 18.481 | 14.938 | 1.169 | 16.716 | 11.649 | 36.585 | 22.798 | 54.417 | 4.428 | 3.529 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 79.891 | 89.944 | 100.015 | 100.120 | 118.561 | 113.126 | 144.295 | 130.767 | 195.404 | 191.892 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Speranta Farmexim Srl